Epidemiology and Risk Factors of Cholangiocarcinoma
- PMID: 28229073
- PMCID: PMC5290446
- DOI: 10.1159/000453013
Epidemiology and Risk Factors of Cholangiocarcinoma
Erratum in
-
Erratum.Visc Med. 2017 Jun;33(3):226. doi: 10.1159/000477195. Epub 2017 Jul 5. Visc Med. 2017. PMID: 28785573 Free PMC article.
Abstract
Background: Cholangiocarcinoma (CCA) is the second most common primary liver cancer, being characterized by its late diagnosis and fatal outcome. Recent epidemiological reports indicate an increasing worldwide incidence of intrahepatic CCA but a decreasing incidence of extrahepatic CCA.
Methods: In this review, we present an overview of the incidence and epidemiology of CCA and possible strategies for screening and surveillance.
Results: Efficient strategies for the screening and surveillance of CCA have not been established so far. The vast majority of CCA occur sporadically without any apparent cause; however, several risk factors such as liver flukes, chronic biliary and liver diseases, and lifestyle-related aspects causing chronic inflammation and cholestasis in the liver have been linked to the development of CCA. These risk factors likely contribute to the increased incidence observed in some countries and also explain the wide geographical differences in the incidence of CCA.
Conclusion: Several risk factors for CCA have been identified. Given the dismal prognosis of advanced CCA, regular surveillance examinations with a combination of ultrasonography and laboratory tests appear to be useful in patients at risk and need to be explored in prospective trials.
Keywords: Cholangiocarcinoma; Epidemiology; Risk factors; Screening; Surveillance.
Similar articles
-
Epidemiology of cholangiocarcinoma.Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):221-32. doi: 10.1016/j.bpg.2015.02.003. Epub 2015 Feb 16. Best Pract Res Clin Gastroenterol. 2015. PMID: 25966423 Review.
-
Cholangiocarcinoma: Epidemiology and risk factors.Liver Int. 2019 May;39 Suppl 1:19-31. doi: 10.1111/liv.14095. Epub 2019 Mar 24. Liver Int. 2019. PMID: 30851228 Review.
-
Cancer review: Cholangiocarcinoma.J Carcinog. 2015 Feb 23;14:1. doi: 10.4103/1477-3163.151940. eCollection 2015. J Carcinog. 2015. PMID: 25788866 Free PMC article. Review.
-
Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma.HPB (Oxford). 2008;10(2):77-82. doi: 10.1080/13651820801992641. HPB (Oxford). 2008. PMID: 18773060 Free PMC article.
-
Cholangiocarcinoma Among Children and Adolescents: A Review of the Literature and Surveillance, Epidemiology, and End Results Program Database Analysis.J Pediatr Gastroenterol Nutr. 2018 Jan;66(1):e12-e18. doi: 10.1097/MPG.0000000000001749. J Pediatr Gastroenterol Nutr. 2018. PMID: 28937543
Cited by
-
IDH1 Targeting as a New Potential Option for Intrahepatic Cholangiocarcinoma Treatment-Current State and Future Perspectives.Molecules. 2020 Aug 18;25(16):3754. doi: 10.3390/molecules25163754. Molecules. 2020. PMID: 32824685 Free PMC article. Review.
-
Targeted Therapies in Cholangiocarcinoma: Emerging Evidence from Clinical Trials.Medicina (Kaunas). 2019 Feb 8;55(2):42. doi: 10.3390/medicina55020042. Medicina (Kaunas). 2019. PMID: 30743998 Free PMC article. Review.
-
Cholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparities.Ann Transl Med. 2019 Dec;7(23):744. doi: 10.21037/atm.2019.12.37. Ann Transl Med. 2019. PMID: 32042760 Free PMC article.
-
Does additional resection of a positive microscopic ductal margin benefit patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis.PLoS One. 2020 May 7;15(5):e0232590. doi: 10.1371/journal.pone.0232590. eCollection 2020. PLoS One. 2020. PMID: 32379819 Free PMC article.
-
Targeting the Sequences of Circulating Tumor DNA of Cholangiocarcinomas and Its Applications and Limitations in Clinical Practice.Int J Mol Sci. 2023 Apr 19;24(8):7512. doi: 10.3390/ijms24087512. Int J Mol Sci. 2023. PMID: 37108676 Free PMC article.
References
-
- Bergquist A, von Seth E. Epidemiology of cholangiocarcinoma. Best Pract Res Clin Gastroenterol. 2015;29:221–232. - PubMed
-
- Plentz RR, Malek NP. Clinical presentation, risk factors and staging systems of cholangiocarcinoma. Best Pract Res Clin Gastroenterol. 2015;29:245–252. - PubMed
-
- Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part III: liver, biliary tract, and pancreas. Gastroenterology. 2009;136:1134–1144. - PubMed
-
- Khan SA, Davidson BR, Goldin RD, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012;61:1657–1669. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical